Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03162796
Brief Title: A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s) (Discover-1)

First Submitted : May 19, 2017
First Submitted that Met QC Criteria : May 19, 2017
First Posted : May 22, 2017

Last Update Submitted that Met QC Criteria : November 26, 2019
Last Update Posted : November 27, 2019